| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation
|
Akil, Ayman
|
|
2015
|
43 |
1 |
p. 99-109
|
artikel
|
| 2 |
Application of a hazard-based visual predictive check to evaluate parametric hazard models
|
Huh, Yeamin
|
|
2015
|
43 |
1 |
p. 57-71
|
artikel
|
| 3 |
Erratum to: Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritis
|
Hu, Chuanpu
|
|
2015
|
43 |
1 |
p. 55
|
artikel
|
| 4 |
Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritis
|
Hu, Chuanpu
|
|
2015
|
43 |
1 |
p. 45-54
|
artikel
|
| 5 |
Model-based approaches for ivabradine development in paediatric population, part II: PK and PK/PD assessment
|
Peigné, Sophie
|
|
2015
|
43 |
1 |
p. 29-43
|
artikel
|
| 6 |
Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessment
|
Peigné, Sophie
|
|
2015
|
43 |
1 |
p. 13-27
|
artikel
|
| 7 |
Population pharmacokinetics of ramosetron
|
Lee, Seong Heon
|
|
2015
|
43 |
1 |
p. 73-83
|
artikel
|
| 8 |
Stochastic nonlinear mixed effects: a metformin case study
|
Matzuka, Brett
|
|
2015
|
43 |
1 |
p. 85-98
|
artikel
|
| 9 |
Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist
|
Ogungbenro, Kayode
|
|
2015
|
43 |
1 |
p. 1-12
|
artikel
|
| 10 |
What do we mean by identifiability in mixed effects models?
|
Lavielle, Marc
|
|
2015
|
43 |
1 |
p. 111-122
|
artikel
|
Tijdschrift beschrijving